HIMSS TV is your Insider’s Guide to everything HIMSS. We are the world’s first online broadcasting network, focused on global innovation and how information and technology are driving change in healthcare.
Matthew Laskowski, CEO of Toby, discusses the machine learning and biomarker analysis technology behind the company’s urine-based multi-cancer detection test that has received FDA Breakthrough Device designation in the United States.